Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy
between this translated document and the Japanese original, the original shall prevail.

July 31, 2023

Consolidated Financial Results
for the Three Months Ended June 30, 2023
(Under Japanese GAAP)
Company name: Taoka Chemical Co., Ltd
Listing:
Tokyo Stock Exchange
Securities code: 4113
URL:
https://www.taoka-chem.co.jp
Representative: Yasuaki Sasaki, President
Inquiries:
Yasuhito Katsumoto, General Manager, Business Services OfficeTelephone:+81-6-7639-7400
Scheduled date to file quarterly securities report:
August 9, 2023
Scheduled date to commence dividend payments:–Preparation of supplementary material on quarterly financial results: None
Holding of quarterly financial results briefing:
None(Yen amounts are rounded down to millions, unless otherwise noted.)

1. Consolidated financial results for the three months ended June 30, 2023 (from April 1,2023 to June 30, 2023)(1) Consolidated operating results (cumulative)
Sales revenue
Three months ended

Millions ofyen%

7,426
8,140(8.8)(8.7)

June 30, 2023
June 30, 2022
Note: Comprehensive income(Percentages indicate year-on-year changes.)

Operating income

Ordinary income

Net income
attributable toowners of theparent

Millions ofyen

Millions ofyen

Millions ofyen%

2 (98.6)
203 (75.2)%

29 (87.1)
225 (73.1)

27 (78.9)
131 (78.2)

For the three months ended June 30, 2023: ¥54 million [(66.0)%]
For the three months ended June 30, 2022: ¥159 million [(73.4)%]

Net income
per share

Diluted net income
per share

Three months endedJune 30, 2023

YenYen1.94－June 30, 2022

9.20－%(2) Consolidated financial position
Total assets
As ofJune 30, 2023
March 31, 2023

Net assets

Equity-to-asset
ratio

Millions of yen

Millions of yen%

30,38931,06916,496
16,57054.3
53.3

Reference: Equity
As of June 30, 2023:
As of March 31, 2023:¥16,496 million¥16,570 million

2. Cash dividends
Annual dividends per share
SecondThird
Fiscal yearquarter-end
quarter-end
end

First
quarter-end
Fiscal year ended
March 31, 2023
Fiscal year ending
March 31, 2024
Fiscal year ending
March 31, 2024
(Forecast)

TotalYen

YenYenYenYen－

18.00

－

9.00

27.00

9.00

－

9.00

18.00

－

Note: Revisions to the forecasts of cash dividends most recently announced: None

3. Consolidated financial forecasts for the fiscal year ending March 31, 2024 (from April 1,2023 to March 31, 2024)(Percentages indicate year-on-year changes.)

Sales revenue
Millions ofyen

Secondquarter-end(Cumulative)
Full year%

Operating income Ordinary income

Net income
attributable toowners of theparent

Millions ofyen

Millions ofyen%Millions ofyen%

Netincomeper share%yen

15,000 (1.7)

150 (39.8)

150 (46.3)

100 (47.7)

6.98

32,000 6.1

700

700 52.9

400

27.92

55.2

Note: Revisions to the forecasts of consolidated financial results most recently announced: None

28.8

* Notes(1) Changes in significant subsidiaries during the period (changes in specified subsidiaries resulting
in the change in scope of consolidation): None
(2) Adoption of accounting treatment specific to the preparation of quarterly consolidated financialstatements: Yes(3) Changes in accounting policies, changes in accounting estimates, and restatement(i) Changes in accounting policies due to revisions to accounting standards and otherregulations: None(ii) Changes in accounting policies due to other reasons: None(iii) Changes in accounting estimates: None(iv) Restatement: None
(4) Number of issued shares (common shares)(i) Total number of issued shares at the end of the period (including treasury shares)
As of June 30, 2023
As of March 31, 2023

14,440,000 shares
14,440,000 shares(ii) Number of treasury shares at the end of the period
As of June 30, 2023
As of March 31, 2023

111,140 shares
111,140 shares(iii) Average number of shares outstanding during the period (cumulative from the beginning ofthe fiscal year)
Three months ended June 30, 2023
Three months ended June 30, 2022

14,328,860 shares
14,328,860 shares* Quarterly financial results reports are exempt from quarterly review conducted by certified public
accountants or an audit corporation.
* Proper use of earnings forecasts, and other special matters(Caution regarding forward-looking statements and others)
The forward-looking statements, including financial forecasts, contained in this report are based on
information currently available to the Company and certain assumptions deemed to be reasonable.
Accordingly, they are not intended to be construed as assurance that they will be accomplished inthe future. Note that actual results may differ materially from the forecasts for a number of reasons.

The Taoka Chemical Group’s consolidated sales revenue for the three months ended June 30, 2023,
decreased by ¥ 713 million compared with the same period of the previous fiscal year, to ¥7,426
million. The Group posted operating income of ¥ 2 million, ordinary income of ¥ 29 million and net
income attributable to owners of the parent of ¥ 27 million.
The financial results of Taoka Chemical by business segment for the three month period were as
follows:
Division

Three Months Ended Three Months Ended
June 30, 2022
June 30, 2023

ChangeMillions of Composition Millions of Composition Millions of Year-on-year
yenratio (%)
yenratio (%)
yenrate (%)

Fine Chemicals
Functional Chemicals
Functional Polymers andAdditives
Chemicals Segment
Analytical Services
Total

4,199

51.6

3,616

48.7

(583)

(13.9)

827

10.2

859

11.6

32

3.9

2,971

36.5

2,814

37.9

(156)

(5.3)

7,997

98.3

7,290

98.2(707)

(8.8)

142

1.7

136

1.8(6)

(4.3)

8,140

100.0

7,426

100.0(713)(8.8)

Note: The “Analytical Services,” which previously composed the “Others” segment, has been presented as areportable segment because its quantitative importance has increased.

Chemicals Segment
Sales revenue of this segment was ¥7,290 million, a ¥707 million decrease compared to the same
period of the previous fiscal year.
Fine Chemicals Division
Though shipments of agrochemical intermediates increased, shipments of monomers for opticalresins decreased. As a result, the division sales revenue decreased by ¥583 million, to ¥3,616
million.
Functional Chemicals Division
A decrease in sales revenue due to a decrease in shipments of rubber additives was outweighed byan increase in sales revenue due to an increase in shipments of adhesives. As a result, the division
sales revenue increased by ¥32 million to ¥859 million.
Functional Polymers and Additives Division
Shipments of plasticizers, paper chemicals and varnish decreased. As a result, the division sales
revenue decreased by ¥156 million, to ¥2,814 million.
Analytical Services Segment
Sales of asbestos analysis and composition and structural analysis decreased. As a result, the segment
sales revenue decreased by ¥6 million, to ¥136 million.